✦ LIBER ✦
14 DUAL ORAL THERAPY WITH THE NS5A INHIBITOR DACLATASVIR (BMS-790052) AND NS3 PROTEASE INHIBITOR ASUNAPREVIR (BMS-650032) IN HCV GENOTYPE 1B-INFECTED NULL RESPONDERS OR INELIGIBLE/INTOLERANT TO PEGINTERFERON/RIBAVIRIN
✍ Scribed by F. Suzuki; K. Ikeda; J. Toyota; Y. Karino; T. Ohmura; K. Chayama; S. Takahashi; Y. Kawakami; H. Ishikawa; H. Watanabe; W. Hu; F. McPhee; E. Hughes; H. Kumada
- Book ID
- 117380228
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 117 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.